Technical Analysis for ABVX - ABIVAX Société Anonyme
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 13.87 | -0.57% | -0.08 |
ABVX closed up 0.72 percent on Wednesday, May 15, 2024, on 2.81 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | -0.57% | |
| NR7 | Range Contraction | -0.57% | |
| Narrow Range Bar | Range Contraction | -0.57% | |
| Inside Day | Range Contraction | -0.57% | |
| Oversold Stochastic | Weakness | -0.57% | |
| Lower Bollinger Band Walk | Weakness | 0.14% | |
| Stochastic Reached Oversold | Weakness | 0.14% | |
| Inside Day | Range Contraction | 0.14% | |
| Down 3 Days in a Row | Weakness | 0.14% | |
| Down 4 Days in a Row | Weakness | 0.14% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 7 minutes ago |
| Up 2% | about 23 hours ago |
| Up 1% | about 23 hours ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Gastroenterology Ulcerative Colitis Colitis Diarrhea
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Gastroenterology Ulcerative Colitis Colitis Diarrhea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.02 |
| 52 Week Low | 7.995 |
| Average Volume | 61,151 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 14.65 |
| 20-Day Moving Average | 14.91 |
| 10-Day Moving Average | 14.32 |
| Average True Range | 0.75 |
| RSI (14) | 37.89 |
| ADX | 25.33 |
| +DI | 13.00 |
| -DI | 19.75 |
| Chandelier Exit (Long, 3 ATRs) | 14.38 |
| Chandelier Exit (Short, 3 ATRs) | 15.63 |
| Upper Bollinger Bands | 16.28 |
| Lower Bollinger Band | 13.54 |
| Percent B (%b) | 0.15 |
| BandWidth | 18.38 |
| MACD Line | -0.23 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.1734 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.37 | ||||
| Resistance 3 (R3) | 14.41 | 14.31 | 14.30 | ||
| Resistance 2 (R2) | 14.31 | 14.20 | 14.29 | 14.28 | |
| Resistance 1 (R1) | 14.13 | 14.13 | 14.08 | 14.09 | 14.26 |
| Pivot Point | 14.02 | 14.02 | 14.00 | 14.01 | 14.02 |
| Support 1 (S1) | 13.85 | 13.92 | 13.79 | 13.81 | 13.64 |
| Support 2 (S2) | 13.74 | 13.85 | 13.72 | 13.62 | |
| Support 3 (S3) | 13.56 | 13.74 | 13.60 | ||
| Support 4 (S4) | 13.53 |
